TY - JOUR AU - Heintz, A. AU - Odicino, F. AU - Maisonneuve, P. AU - Quinn, M. A. AU - Benedet, J. L. AU - Creasman, W. T. PY - 2006 DA - 2006// TI - Carcinoma of the ovary JO - Int J Gynaecol Obstet VL - 95 UR - https://doi.org/10.1016/S0020-7292(06)60033-7 DO - 10.1016/S0020-7292(06)60033-7 ID - Heintz2006 ER - TY - STD TI - Kurman RJ. International Agency for Research on Cancer., World Health Organization. WHO classification of tumours of female reproductive organs. Lyon: International Agency for Research on Cancer. 2014:307. ID - ref2 ER - TY - JOUR AU - Morales-Vasquez, F. AU - Pedernera, E. AU - Reynaga-Obregon, J. AU - Lopez-Basave, H. N. AU - Gomora, M. J. AU - Carlon, E. PY - 2016 DA - 2016// TI - High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma JO - J Ovarian Res. VL - 9 UR - https://doi.org/10.1186/s13048-016-0247-6 DO - 10.1186/s13048-016-0247-6 ID - Morales-Vasquez2016 ER - TY - JOUR AU - Jacobs, I. J. AU - Menon, U. AU - Ryan, A. AU - Gentry-Maharaj, A. AU - Burnell, M. AU - Kalsi, J. K. PY - 2016 DA - 2016// TI - Ovarian cancer screening and mortality in the UK collaborative trial of ovarian Cancer screening (UKCTOCS): a randomised controlled trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01224-6 DO - 10.1016/S0140-6736(15)01224-6 ID - Jacobs2016 ER - TY - JOUR AU - Henderson, J. T. AU - Webber, E. M. AU - Sawaya, G. F. PY - 2018 DA - 2018// TI - Screening for ovarian Cancer: updated evidence report and systematic review for the US preventive services task force JO - JAMA VL - 319 UR - https://doi.org/10.1001/jama.2017.21421 DO - 10.1001/jama.2017.21421 ID - Henderson2018 ER - TY - JOUR AU - Kamal, R. AU - Hamed, S. AU - Mansour, S. AU - Mounir, Y. AU - Abdel Sallam, S. PY - 2018 DA - 2018// TI - Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality JO - Br J Radiol VL - 91 UR - https://doi.org/10.1259/bjr.20170571 DO - 10.1259/bjr.20170571 ID - Kamal2018 ER - TY - STD TI - Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21492. ID - ref7 ER - TY - JOUR AU - Arias-Pulido, H. AU - Smith, H. O. AU - Joste, N. E. AU - Bocklage, T. AU - Qualls, C. R. AU - Chavez, A. PY - 2009 DA - 2009// TI - Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors JO - Gynecol Oncol VL - 114 UR - https://doi.org/10.1016/j.ygyno.2009.05.045 DO - 10.1016/j.ygyno.2009.05.045 ID - Arias-Pulido2009 ER - TY - JOUR AU - Zhao, D. AU - Zhang, F. AU - Zhang, W. AU - He, J. AU - Zhao, Y. AU - Sun, J. PY - 2013 DA - 2013// TI - Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis JO - Int J Gynecol Cancer VL - 23 UR - https://doi.org/10.1097/IGC.0b013e3182788466 DO - 10.1097/IGC.0b013e3182788466 ID - Zhao2013 ER - TY - JOUR AU - Feng, Z. AU - Wen, H. AU - Bi, R. AU - Ju, X. AU - Chen, X. AU - Yang, W. PY - 2016 DA - 2016// TI - A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep25408 DO - 10.1038/srep25408 ID - Feng2016 ER - TY - JOUR AU - Salehi, F. AU - Dunfield, L. AU - Phillips, K. P. AU - Krewski, D. AU - Vanderhyden, B. C. PY - 2008 DA - 2008// TI - Risk factors for ovarian cancer: an overview with emphasis on hormonal factors JO - J Toxicol Environ Health B Crit Rev VL - 11 UR - https://doi.org/10.1080/10937400701876095 DO - 10.1080/10937400701876095 ID - Salehi2008 ER - TY - JOUR AU - Sieh, W. AU - Kobel, M. AU - Longacre, T. A. AU - Bowtell, D. D. AU - deFazio, A. AU - Goodman, M. T. PY - 2013 DA - 2013// TI - Hormone-receptor expression and ovarian cancer survival: an ovarian tumor tissue analysis consortium study JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70253-5 DO - 10.1016/S1470-2045(13)70253-5 ID - Sieh2013 ER - TY - JOUR AU - Lee, P. AU - Rosen, D. G. AU - Zhu, C. AU - Silva, E. G. AU - Liu, J. PY - 2005 DA - 2005// TI - Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer JO - Gynecol Oncol VL - 96 UR - https://doi.org/10.1016/j.ygyno.2004.11.010 DO - 10.1016/j.ygyno.2004.11.010 ID - Lee2005 ER - TY - JOUR AU - Hogdall, E. V. AU - Christensen, L. AU - Hogdall, C. K. AU - Blaakaer, J. AU - Gayther, S. AU - Jacobs, I. J. PY - 2007 DA - 2007// TI - Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study JO - Oncol Rep VL - 18 ID - Hogdall2007 ER - TY - JOUR AU - Lenhard, M. AU - Tereza, L. AU - Heublein, S. AU - Ditsch, N. AU - Himsl, I. AU - Mayr, D. PY - 2012 DA - 2012// TI - Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-553 DO - 10.1186/1471-2407-12-553 ID - Lenhard2012 ER - TY - JOUR AU - Matsuo, K. AU - Sheridan, T. B. AU - Mabuchi, S. AU - Yoshino, K. AU - Hasegawa, K. AU - Studeman, K. D. PY - 2014 DA - 2014// TI - Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma JO - Gynecol Oncol VL - 133 UR - https://doi.org/10.1016/j.ygyno.2014.03.563 DO - 10.1016/j.ygyno.2014.03.563 ID - Matsuo2014 ER - TY - JOUR AU - Nodin, B. AU - Zendehrokh, N. AU - Brandstedt, J. AU - Nilsson, E. AU - Manjer, J. AU - Brennan, D. J. PY - 2010 DA - 2010// TI - Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival JO - J Ovarian Res VL - 3 UR - https://doi.org/10.1186/1757-2215-3-14 DO - 10.1186/1757-2215-3-14 ID - Nodin2010 ER - TY - JOUR AU - Shen, Z. AU - Luo, H. AU - Li, S. AU - Sheng, B. AU - Zhao, M. AU - Zhu, H. PY - 2017 DA - 2017// TI - Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis JO - Oncotarget VL - 8 ID - Shen2017 ER - TY - JOUR AU - Li, A. J. AU - Baldwin, R. L. AU - Karlan, B. Y. PY - 2003 DA - 2003// TI - Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma JO - Clin Cancer Res VL - 9 ID - Li2003 ER - TY - JOUR AU - Syed, V. AU - Zhang, X. AU - Lau, K. M. AU - Cheng, R. AU - Mukherjee, K. AU - Ho, S. M. PY - 2005 DA - 2005// TI - Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208959 DO - 10.1038/sj.onc.1208959 ID - Syed2005 ER - TY - JOUR AU - Syed, V. AU - Ulinski, G. AU - Mok, S. C. AU - Yiu, G. K. AU - Ho, S. M. PY - 2001 DA - 2001// TI - Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells JO - Cancer Res VL - 61 ID - Syed2001 ER - TY - JOUR AU - Bu, S. Z. AU - Yin, D. L. AU - Ren, X. H. AU - Jiang, L. Z. AU - Wu, Z. J. AU - Gao, Q. R. PY - 1997 DA - 1997// TI - Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines JO - Cancer VL - 79 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Bu1997 ER - TY - JOUR AU - Syed, V. AU - Ho, S. M. PY - 2003 DA - 2003// TI - Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206828 DO - 10.1038/sj.onc.1206828 ID - Syed2003 ER - TY - JOUR AU - Syed, V. AU - Mukherjee, K. AU - Lyons-Weiler, J. AU - Lau, K. M. AU - Mashima, T. AU - Tsuruo, T. PY - 2005 DA - 2005// TI - Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1207991 DO - 10.1038/sj.onc.1207991 ID - Syed2005 ER - TY - JOUR AU - Valladares, M. AU - Plaza-Parrochia, F. AU - Lepez, M. AU - Lopez, D. AU - Gabler, F. AU - Gayan, P. PY - 2017 DA - 2017// TI - Effect of estradiol on the expression of angiogenic factors in epithelial ovarian cancer JO - Histol Histopathol VL - 32 ID - Valladares2017 ER - TY - JOUR AU - Werner, A. AU - Aichberger, A. AU - Krebs, D. PY - 1996 DA - 1996// TI - Does interferon-alpha enhance the effect of tamoxifen-medroxyprogesterone acetate and hydroxyflutamide on in vitro tumor cells? JO - Zentralbl Gynakol VL - 118 ID - Werner1996 ER - TY - JOUR AU - Remmele, W. AU - Stegner, H. E. PY - 1987 DA - 1987// TI - Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue JO - Pathologe VL - 8 ID - Remmele1987 ER - TY - JOUR AU - Turin, I. S. R. AU - Maestri, M. AU - Luinetti, O. AU - Dal Bello, B. AU - Paulli, M. PY - 2014 DA - 2014// TI - In vitro efficient expansion of tumor cells deriving from different types of human tumor samples JO - Med Sci VL - 2 ID - Turin2014 ER - TY - STD TI - Gomora MJ, Morales-Vasquez F, Pedernera E, Perez-Montiel D, Lopez-Basave H, Villa AR, et al. Sexual steroid hormone receptors profiles in ovarian carcinoma in Mexican women. Endocr Connect. 2018. ID - ref29 ER - TY - JOUR AU - Plaza-Parrochia, F. AU - Romero, C. AU - Valladares, L. AU - Vega, M. PY - 2017 DA - 2017// TI - Endometrium and steroids, a pathologic overview JO - Steroids VL - 126 UR - https://doi.org/10.1016/j.steroids.2017.08.007 DO - 10.1016/j.steroids.2017.08.007 ID - Plaza-Parrochia2017 ER - TY - JOUR AU - Modugno, F. AU - Laskey, R. AU - Smith, A. L. AU - Andersen, C. L. AU - Haluska, P. AU - Oesterreich, S. PY - 2012 DA - 2012// TI - Hormone response in ovarian cancer: time to reconsider as a clinical target? JO - Endocr Relat Cancer VL - 19 UR - https://doi.org/10.1530/ERC-12-0175 DO - 10.1530/ERC-12-0175 ID - Modugno2012 ER - TY - JOUR AU - Diep, C. H. AU - Daniel, A. R. AU - Mauro, L. J. AU - Knutson, T. P. AU - Lange, C. A. PY - 2015 DA - 2015// TI - Progesterone action in breast, uterine, and ovarian cancers JO - J Mol Endocrinol VL - 54 UR - https://doi.org/10.1530/JME-14-0252 DO - 10.1530/JME-14-0252 ID - Diep2015 ER - TY - JOUR AU - Wu, N. Y. AU - Huang, H. S. AU - Chao, T. H. AU - Chou, H. M. AU - Fang, C. AU - Qin, C. Z. PY - 2017 DA - 2017// TI - Progesterone prevents high-grade serous ovarian Cancer by inducing necroptosis of p53-defective fallopian tube epithelial cells JO - Cell Rep VL - 14 UR - https://doi.org/10.1016/j.celrep.2017.02.049 DO - 10.1016/j.celrep.2017.02.049 ID - Wu2017 ER - TY - JOUR AU - Eisenhofer, G. AU - Peitzsch, M. AU - Kaden, D. AU - Langton, K. AU - Pamporaki, C. AU - Masjkur, J. PY - 2017 DA - 2017// TI - Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and bloodpressure status JO - Clin Chim Acta. VL - 470 UR - https://doi.org/10.1016/j.cca.2017.05.002 DO - 10.1016/j.cca.2017.05.002 ID - Eisenhofer2017 ER - TY - JOUR AU - Mohammed, H. AU - Russell, I. A. AU - Stark, R. AU - Rueda, O. M. AU - Hickey, T. E. AU - Tarulli, G. A. PY - 2015 DA - 2015// TI - Progesterone receptor modulates ERalpha action in breast cancer JO - Nature VL - 523 UR - https://doi.org/10.1038/nature14583 DO - 10.1038/nature14583 ID - Mohammed2015 ER -